Literature DB >> 25177373

Establishment of animal models with orthotopic hepatocellular carcinoma.

Tai Kyoung Lee1, Kyung Sook Na1, Jeonghun Kim1, Hwan-Jeong Jeong1.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most serious health problems worldwide. Many researchers have investigated HCC at the level of genes, ribonucleic acid, proteins, cells, and animals. The resultant development of animal models and monitoring methods has improved the effectiveness of guidelines provided to researchers working with preclinical HCC models. HCC in animal models and clinical patients is monitored by various current imaging modalities such as ultrasound (US) imaging, computed tomography (CT), magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT), positron emission tomography (PET) and bioluminescence imaging (BLI). These techniques are currently used for both preclinical and clinical assessment, and provide valuable diagnostic information. In this article, we have mainly reviewed the established animal models and the assessment of orthotopic HCC using imaging modalities. Additionally, we have introduced a method of orthotopic HCC rat model developed in our laboratory. We have furthermore evaluated the occurrence of tumor mass using molecular imaging techniques.

Entities:  

Keywords:  Cyclosphorin A; Hepatocellular carcinoma; Hepatoma; McA-7777; Molecular imaging; N1S1; Orthotopic HCC

Year:  2014        PMID: 25177373      PMCID: PMC4145097          DOI: 10.1007/s13139-014-0288-y

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  42 in total

Review 1.  Comparative overview of brain perfusion imaging techniques.

Authors:  M Wintermark; M Sesay; E Barbier; K Borbély; W P Dillon; J D Eastwood; T C Glenn; C B Grandin; S Pedraza; J F Soustiel; T Nariai; G Zaharchuk; J M Caillé; V Dousset; H Yonas
Journal:  J Neuroradiol       Date:  2005-12       Impact factor: 3.447

2.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

Authors:  Y Li; Z Y Tang; S L Ye; Y K Liu; J Chen; Q Xue; J Chen; D M Gao; W H Bao
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Establishment of primary xenograft model from newly characterized patient extrauterine carcinosarcoma.

Authors:  Hyun Joo Lee; Hye-Jung Choi; Heung-Mo Yang; You Min Kim; Jeeyun Lee; Dongil Chio; Bokyung Kim; Yoon-La Choi; Sung Joo Kim
Journal:  Int J Gynecol Cancer       Date:  2013-11       Impact factor: 3.437

Review 4.  Role of the microenvironment in hepatocellular carcinoma development and progression.

Authors:  Sheng-Di Wu; Yu-Shui Ma; Ying Fang; Li-Li Liu; Da Fu; Xi-Zhong Shen
Journal:  Cancer Treat Rev       Date:  2011-07-16       Impact factor: 12.111

5.  Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.

Authors:  Partha K Chandra; Anup K Kundu; Sidhartha Hazari; Sruti Chandra; Lili Bao; Tara Ooms; Gilbert F Morris; Tong Wu; Tarun K Mandal; Srikanta Dash
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

6.  Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.

Authors:  Yuan-Fei Peng; Ying-Hong Shi; Zhen-Bin Ding; Ai-Wu Ke; Cheng-Yu Gu; Bo Hui; Jian Zhou; Shuang-Jian Qiu; Zhi Dai; Jia Fan
Journal:  Autophagy       Date:  2013-10-01       Impact factor: 16.016

7.  High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients.

Authors:  Tan To Cheung; Sheung Tat Fan; See Ching Chan; Kenneth S H Chok; Ferdinand S K Chu; Caroline R Jenkins; Regina C L Lo; James Y Y Fung; Albert C Y Chan; William W Sharr; Simon H Y Tsang; Wing Chiu Dai; Ronnie T P Poon; Chung Mau Lo
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

8.  Spontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies.

Authors:  Manon Buijs; Jean-Francois H Geschwind; Labiq H Syed; Shanmugasundaram Ganapathy-Kanniappan; Rani Kunjithapatham; Joost W Wijlemans; Byung Kook Kwak; Shinichi Ota; Mustafa Vali
Journal:  J Vasc Interv Radiol       Date:  2012-12       Impact factor: 3.464

9.  Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival.

Authors:  J R Rogosheske; A D Fargen; T E DeFor; E Warlick; M Arora; B R Blazar; D J Weisdorf; C G Brunstein
Journal:  Bone Marrow Transplant       Date:  2013-09-16       Impact factor: 5.483

10.  Reversal of Taxol resistance in hepatoma by cyclosporin A: involvement of the PI-3 kinase-AKT 1 pathway.

Authors:  H-L Lin; W-Y Lui; T-Y Liu; C-W Chi
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

View more
  5 in total

1.  Ultrasound cavitation enhanced chemotherapy: In vivo research and clinical application.

Authors:  Zhiyong Shen; Jingjing Shao; Jianquan Zhang; Weixing Qu
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-20

2.  Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways.

Authors:  Nicola Bortel; Sorin Armeanu-Ebinger; Evi Schmid; Bettina Kirchner; Jan Frank; Alexa Kocher; Christina Schiborr; Steven Warmann; Jörg Fuchs; Verena Ellerkamp
Journal:  Oncotarget       Date:  2015-12-01

3.  Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma.

Authors:  A Galal El-Shemi; A Mohammed Ashshi; E Oh; B-K Jung; M Basalamah; A Alsaegh; C-O Yun
Journal:  Gene Ther       Date:  2017-09-19       Impact factor: 5.250

4.  5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway.

Authors:  Federica Tonon; Maja Cemazar; Urska Kamensek; Cristina Zennaro; Gabriele Pozzato; Sergio Caserta; Flora Ascione; Mario Grassi; Stefano Guido; Cinzia Ferrari; Laura Cansolino; Francesco Trotta; Biljana Grcar Kuzmanov; Giancarlo Forte; Fabiana Martino; Francesca Perrone; Riccardo Bomben; Valter Gattei; Nicola Elvassore; Erminio Murano; Nhung Hai Truong; Michael Olson; Rossella Farra; Gabriele Grassi; Barbara Dapas
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

5.  Early response evaluation of doxorubicin-nanoparticle-microbubble therapy in orthotopic hepatocellular carcinoma rat model using contrast-enhanced ultrasound and intravoxel incoherent motion-diffusion MRI.

Authors:  Hyun Kyung Yang; Jung Hoon Kim; Hak Jong Lee; Hyungwon Moon; Hwaseong Ryu; Joon Koo Han
Journal:  Ultrasonography       Date:  2021-05-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.